RAPP - Rapport Therapeutics Inc.
36.36
-0.420 -1.155%
Share volume: 304,756
Last Updated: 04-23-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$36.78
-0.42
-0.01%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 08-08-2024 | 11-07-2024 | 03-11-2025 | 05-08-2025 | 11-06-2025 | 03-10-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 20.800 M | 21.640 M | 0.000 | 27.108 M | 29.986 M | 38.509 M | |
| Selling general and admin | 5.111 M | 6.097 M | 0.000 | 7.536 M | 7.707 M | 8.251 M | |
| Research and development | 15.689 M | 15.543 M | 0.000 | 19.572 M | 22.279 M | 30.258 M | |
| Total expenses | 20.800 M | 21.640 M | 0.000 | 27.108 M | 29.986 M | 38.509 M | |
| 4.04% | -100.00% | 10.62% | 28.42% | ||||
| Operating income | -20.800 M | -21.640 M | 0.000 | -27.108 M | -29.986 M | -38.509 M | |
| Ebit | -20.800 M | -21.640 M | 0.000 | -27.108 M | -29.986 M | -38.509 M | |
| Pretax income | -18.121 M | -17.537 M | 0.000 | -24.063 M | -26.925 M | -33.763 M | |
| -3.22% | -100.00% | 11.89% | 25.40% | ||||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -18.121 M | -17.537 M | 0.000 | -24.063 M | -26.925 M | -33.763 M | |
| 3.22% | 100.00% | -11.89% | -25.40% |